{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:42:58Z","timestamp":1790678578299,"version":"4.1.0"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,22]]},"DOI":"10.18632\/oncotarget.12749","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T16:36:09Z","timestamp":1476894969000},"page":"77635-77650","source":"Crossref","is-referenced-by-count":14,"title":["Bcr-abl regulates Stat5 through Shp2, the interferon consensus sequence binding protein (Icsbp\/Irf8), growth arrest specific 2 (Gas2) and calpain"],"prefix":"10.18632","volume":"7","author":[{"given":"Elizabeth E.","family":"Hjort","sequence":"first","affiliation":[{"name":"The Feinberg School at Northwestern University, Chicago, IL, USA"},{"name":"Jesse Brown VA Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Huang","sequence":"additional","affiliation":[{"name":"The Feinberg School at Northwestern University, Chicago, IL, USA"},{"name":"Jesse Brown VA Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Hu","sequence":"additional","affiliation":[{"name":"The Feinberg School at Northwestern University, Chicago, IL, USA"},{"name":"Jesse Brown VA Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Eklund","sequence":"additional","affiliation":[{"name":"The Feinberg School at Northwestern University, Chicago, IL, USA"},{"name":"Jesse Brown VA Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,10,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1200\/JCO.2010.31.3619","article-title":"Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in CML","volume":"29","author":"Kantarjian","year":"2011","journal-title":"J. Clin. Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.critrevonc.2014.11.001","article-title":"Mechanisms of resistance to BCR-ABL TKIs and the therapeutic strategies: A review","volume":"93","author":"Fu","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ajh.23902","article-title":"Molecular monitoring to improve outcomes in patients with chronic myeloid leukemia in chronic phase: Importance of achieving treatment-free remission","volume":"90","author":"Erba","year":"2015","journal-title":"Am. J. Hematol"},{"key":"5","first-page":"186","article-title":"Second-line therapy for patients with Chronic Myeloid Leukemia resistant to first-line imatinib","volume":"14","author":"Seiter","year":"2104","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of IM in patients with CML who have maintained complete molecular remission for at least 2 years","volume":"11","author":"Rousselot","year":"2010","journal-title":"Lancet Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood-2012-07-441956","article-title":"Model-based decision rules reduce the risk of molecular relapse after cessation of tyrosine kinase inhibitor therapy in chronic myeloid leukemia","volume":"121","author":"Roeder","year":"2013","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2013-02-483750","article-title":"Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study","volume":"122","author":"Melo","year":"2013","journal-title":"Blood"},{"key":"9","unstructured":"Oncomine, Research Addition. University of Michigan, Ann Arbor. www.oncomine.org."},{"key":"10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood.V91.1.22","article-title":"Lack of interferon consensus sequence binding protein transcripts in human myeloid leukemias","volume":"91","author":"Neubauer","year":"1998","journal-title":"Blood"},{"key":"11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1128\/MCB.20.4.1149-1161.2000","article-title":"Expression of ICSBP is down-regulated in bcr-abl-induced murine CML and forced co-expression of ICSBP inhibits bcr-abl-induced MPD","volume":"20","author":"Ren","year":"2000","journal-title":"Mol. Cell. Biol"},{"key":"12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81348-3","article-title":"Immuno-deficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene","volume":"87","author":"Zinkernagel","year":"1996","journal-title":"Cell"},{"key":"13","first-page":"853","article-title":"Constitutive activation of SHP2 cooperates with ICSBP-deficiency to accelerate progression to acute myeloid leukemia","volume":"118","author":"Eklund","year":"2008","journal-title":"J. Clin. Invest"},{"key":"14","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.1074\/jbc.M706710200","article-title":"The interferon consensus sequence binding protein (ICSBP\/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells","volume":"283","author":"Eklund","year":"2008","journal-title":"J. Biol. Chem"},{"key":"15","first-page":"619","article-title":"Fas-Associated Phosphatase 1 (Fap1) Mediates Fas-Resistance in Myeloid Progenitor Cells expressing the Bcr-abl Oncogene","volume":"54","author":"Eklund","year":"2012","journal-title":"Leuk.Lymphoma"},{"key":"16","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1128\/MCB.01595-09","article-title":"The Interferon Consensus Sequence Binding Protein (ICSBP) decreases Bcatenin-activity in myeloid cells by repressing GAS2 transcription","volume":"30","author":"Eklund","year":"2010","journal-title":"Mol. Cell. Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1128\/MCB.00036-06","article-title":"Leukemia associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1-transcriptional activation by the interferon consensus sequence binding protein","volume":"26","author":"Eklund","year":"2006","journal-title":"Mol. and Cell. Biol"},{"key":"18","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1182\/blood-2003-08-2970","article-title":"Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR\/ABL and down-regulates bcl-2","volume":"103","author":"Neubauer","year":"2004","journal-title":"Blood"},{"key":"19","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1182\/blood-2012-06-437863","article-title":"Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation","volume":"121","author":"Tamura","year":"2013","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1074\/jbc.M112.429696","article-title":"Fas associated phosphatase 1 (Fap1) influences \u03b2catenin activity in myeloid progenitor cells expressing the Bcr-abl oncogene","volume":"288","author":"Eklund","year":"2013","journal-title":"J Biol Chem"},{"key":"21","doi-asserted-by":"crossref","first-page":"24082","DOI":"10.1016\/S0021-9258(19)51050-X","article-title":"Cloning and characterization of PTPL1, a PTP with similarities to cytoskeletal-associated proteins","volume":"269","author":"Gonex","year":"1994","journal-title":"J. Biol. Chem"},{"key":"22","doi-asserted-by":"crossref","first-page":"8539","DOI":"10.1074\/jbc.272.13.8539","article-title":"The molecular interaction of Fas and Fap1","volume":"272","author":"Sato","year":"1997","journal-title":"J. Biol. Chem"},{"key":"23","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/leu.2016.66","article-title":"The role of Fas-associated phosphatase 1 in leukemia stem cell persistence during tyrosine kinase inhibitor treatment of chronic myeloid leukemia","volume":"30","author":"Eklund","year":"2016","journal-title":"Leukemia"},{"key":"24","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1093\/emboj\/20.11.2702","article-title":"The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis","volume":"20","author":"Schneider","year":"2001","journal-title":"EMBO J"},{"key":"25","doi-asserted-by":"crossref","first-page":"22070","DOI":"10.1074\/jbc.M501810200","article-title":"The calpain system is involved in the constitutive regulation of \u03b2catenin signaling functions","volume":"280","author":"Schneider","year":"2005","journal-title":"J. Biol. Chem"},{"key":"26","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood.V99.5.1850","article-title":"Calpain is a signal transducer and activator of transcription (STAT) 3 and STAT5 protease","volume":"99","author":"Fujita","year":"2002","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1189\/jlb.0704429","article-title":"JAK2 is necessary and sufficient for interferon gamma-induced transcription of the gene encoding gp91","volume":"77","author":"Eklund","year":"2005","journal-title":"J. Leukocyte Biol"},{"key":"28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/leu.2012.308","article-title":"The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo","volume":"27","author":"Yu","year":"2013","journal-title":"Leukemia"},{"key":"29","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/blood-2005-08-3087","article-title":"Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)","volume":"107","author":"Eder","year":"2006","journal-title":"Blood"},{"key":"30","first-page":"37868","article-title":"SHP1 protein tyrosine phosphatase inhibits transcription of theandgenes in undifferentiated myeloid cell lines by inhibiting interaction of PU.1, IRF1, ICSBP and CBP","volume":"276","author":"Eklund","year":"2001","journal-title":"J. Biol. Chem"},{"key":"31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.immuni.2008.02.013","article-title":"The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8","volume":"28","author":"Watowich","year":"2008","journal-title":"Immunity"},{"key":"32","doi-asserted-by":"crossref","first-page":"15642","DOI":"10.1074\/jbc.M113.544320","article-title":"Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemia","volume":"289","author":"Abrams","year":"2014","journal-title":"J Biol Chem"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Flicek, Amode, Barrell, Beal, Billis, Brent, Carvalho-Silva, Clapham, Coates, Fitzgerald, Gil, Garc\u00eda Gir\u00f3n, Gordon, et al. Ensembl 2014. Nucleic Acids Research. 2014; 42. Database issue; D749\u2013D755.","DOI":"10.1093\/nar\/gkt1196"},{"key":"34","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/MCB.18.7.3871","article-title":"Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation","volume":"18","author":"Kitamura","year":"1998","journal-title":"Mol Cell Biol"},{"key":"35","doi-asserted-by":"crossref","first-page":"W273","DOI":"10.1093\/nar\/gkh458","article-title":"VISTA: computational tools for comparative genomics","volume":"32","author":"Dubchak","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1002\/j.1460-2075.1994.tb06756.x","article-title":"Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription","volume":"13","author":"Groner","year":"1994","journal-title":"EMBO J"},{"key":"37","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.V95.6.2118","article-title":"STAT5 activation contributes to growth and viability in Bcr\/Abl-transformed cells","volume":"95","author":"Griffin","year":"2000","journal-title":"Blood"},{"key":"38","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1182\/blood-2005-10-4110","article-title":"STAT5 signaling is required for the efficient induction and maintenance of CML in mice","volume":"107","author":"Ilaria","year":"2006","journal-title":"Blood"},{"key":"39","doi-asserted-by":"crossref","first-page":"33968","DOI":"10.1074\/jbc.M203350200","article-title":"Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia","volume":"277","author":"Takahashi","year":"2002","journal-title":"J Biol Chem"},{"key":"40","doi-asserted-by":"crossref","first-page":"13957","DOI":"10.1074\/jbc.273.22.13957","article-title":"PU.1, interferon regulatory factor 1, and interferon consensus sequence binding protein cooperate to increase gp91expression","volume":"273","author":"Kakar","year":"1998","journal-title":"J. Biol. Chem"},{"key":"41","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.4049\/jimmunol.163.11.6095","article-title":"Kakar R Recruitment of CBP by PU.1, IRF1 and ICSBP is necessary for gp91and p67phox expression","volume":"163","author":"Eklund","year":"1999","journal-title":"J. Immunol"},{"key":"42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4049\/jimmunol.125.1.6","article-title":"Characterization of a human macrophage-like cell line stimulated to differentiate in vitro: a model of macrophage functions","volume":"125","author":"Koren","year":"1980","journal-title":"J. Immunol"},{"key":"43","doi-asserted-by":"crossref","first-page":"17967","DOI":"10.1073\/pnas.0808303105","article-title":"BCR-ABL-transformed GMP as myeloid leukemic stem cells","volume":"105","author":"Wang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T14:32:48Z","timestamp":1692541968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,19]]},"references-count":43,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2016,11,22]]}},"alternative-id":["12749","27769062"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12749","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,19]]}}}